Gilead Sciences
GILD
#97
Rank
C$241.44 B
Marketcap
C$194.52
Share price
0.48%
Change (1 day)
22.33%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): C$9.50

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C$9.51. In 2024 the company made an earnings per share (EPS) of C$0.53 a decrease over its 2023 EPS that were of C$6.32.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$9.501699.22%
2024C$0.53-91.65%
2023C$6.3223.98%
2022C$5.10-25.86%
2021C$6.884850%
2020C$0.14-97.64%
2019C$5.890.9%
2018C$5.8418.71%
2017C$4.92-64.88%
2016C$14.00-18.45%
2015C$17.1755.28%
2014C$11.06296.02%
2013C$2.7917.89%
2012C$2.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.47 62.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.89-80.15%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$3.32-65.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.98 236.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$19.90 109.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$12.27 28.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.61-20.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$21.49 125.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.15 6.72%๐Ÿ‡บ๐Ÿ‡ธ USA